Search in:

Drug Design, Development and Therapy Volume 10, 2016 - Issue

Submit an article Journal homepage

Open access

137

Views

CrossRef citations to date

Altmetric

Letter

Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromes

Ali T Taher1 Department of Internal Medicine, American University of Beirut, Beirut, LebanonCorrespondence[email protected]

John B Porter2 Department of Haematology, University College London, London, UK

Antonis Kattamis3 First Department of Pediatrics, University of Athens, Athens, Greece

Vip Viprakasit4 Department of Pediatrics and Thalassemia Center, Siriraj Hospital, Mahidol University, Bangkok, Thailand

M Domenica Cappellini5 Department of Internal Medicine, Università di Milano, Ca Granda Foundation IRCCS, Milan, Italy

Pages 4073-4078 | Published online: 15 Dec 2016

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (12)

Sarina Entezari, Seyedeh Mona Haghi, Narges Norouzkhani, Barsa Sahebnazar, Fatemeh Vosoughian, Diba Akbarzadeh, Muhammad Islampanah, Navid Naghsh, Mohammad Abbasalizadeh & Niloofar Deravi. (2022) Iron Chelators in Treatment of Iron Overload. Journal of Toxicology 2022, pages 1-18.
Crossref

George J. Kontoghiorghes. (2022) Questioning Established Theories and Treatment Methods Related to Iron and Other Metal Metabolic Changes, Affecting All Major Diseases and Billions of Patients. International Journal of Molecular Sciences 23:3, pages 1364.
Crossref

George J. Kontoghiorghes. (2021) Differences between the European Union and United States of America in Drug Regulatory Affairs Affect Global Patient Safety Standards and Public Health Awareness: The Case of Deferasirox and Other Iron Chelating Drugs. Medicines 8:7, pages 36.
Crossref

Maura Argenziano, Alessandra Di Paola, Chiara Tortora, Daniela Di Pinto, Elvira Pota, Martina Di Martino, Silverio Perrotta, Francesca Rossi & Francesca Punzo. (2021) Effects of Iron Chelation in Osteosarcoma. Current Cancer Drug Targets 21:5, pages 443-455.
Crossref

Jumana Saleh, Carole Peyssonnaux, Keshav K Singh & Marvin Edeas. (2020) Mitochondria and microbiota dysfunction in COVID-19 pathogenesis. Mitochondrion 54, pages 1-7.
Crossref

Francesca Vinchi, Saskia Hell & Uwe Platzbecker. (2020) Controversies on the Consequences of Iron Overload and Chelation in MDS. HemaSphere 4:3, pages e357.
Crossref

Ricardo U. Macías-Rodríguez, María Eugenia Inzaugarat, Astrid Ruiz-Margáin, Leonard J. Nelson, Christian Trautwein & Francisco Javier Cubero. (2020) Reclassifying Hepatic Cell Death during Liver Damage: Ferroptosis—A Novel Form of Non-Apoptotic Cell Death?. International Journal of Molecular Sciences 21:5, pages 1651.
Crossref

Pimpisid Koonyosying, Adisak Tantiworawit, Sasinee Hantrakool, Niramon Utama-ang, Michael Cresswell, Suthat Fucharoen, John B. Porter & Somdet Srichairatanakool. (2020) Consumption of a green tea extract–curcumin drink decreases blood urea nitrogen and redox iron in β-thalassemia patients. Food & Function 11:1, pages 932-943.
Crossref

Ari EstuningtyasKlaus ZwickerTri WahyuniPurnama FajriPustika Amalia WahidiyatSeruni K.U. FreislebenHans-Joachim Freisleben. (2018) Are Mangiferin and Mangiferin-Containing Plant Extracts Helpful for Iron-Loaded Transfusion-Dependent and Non-Transfusion-Dependent Thalassaemia Patients?. Biomedical and Pharmacology Journal 11:1, pages 29-43.
Crossref

Kalyani Dhusia, Archana Bajpai & P.W. Ramteke. (2018) RETRACTED: Overcoming antibiotic resistance: Is siderophore trojan horse conjugation an answer to evolving resistance in microbial pathogens?. Journal of Controlled Release 269, pages 63-87.
Crossref

Tania Banerjee & Rohit B Aniyery. (2017) Thalassemia and its Management during Pregnancy. World Journal of Anemia 1:1, pages 5-17.
Crossref

Joshua P. Gray, Natalia Suhali-Amacher & Sidhartha D. Ray. 2017. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions 197 208 .

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromes

Articles from other publishers (12)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromes

Citations (12)

Articles from other publishers (12)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date